XML 88 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Balance Sheet Details
12 Months Ended
Dec. 31, 2012
Balance Sheet Details [Abstract]  
Balance Sheet Details

6.    Balance Sheet Details

Inventory

Inventories are recorded at standard cost on a first-in, first-out basis. Inventories consist of the following (in thousands) as of:

 

                 
    December 31,
2012
    December 31,
2011
 

Raw materials

  $ 325     $ 353  

Work in progress

    597       495  

Finished goods

    5,293       5,699  
   

 

 

   

 

 

 
      6,215       6,547  

Reserve

    (904     (224
   

 

 

   

 

 

 

Net inventory

  $ 5,311     $ 6,323  
   

 

 

   

 

 

 

The Company reviews inventory periodically and reduces the carrying value of items considered to be slow moving or obsolete to their estimated net realizable value. The Company considers several factors in estimating the net realizable value, including shelf lives of raw materials, estimated demand for its enzyme products and historical write-offs.

Property and equipment

Property and equipment is stated at cost and depreciated over the estimated useful lives of the assets (generally three to five years) using the straight-line method.

Property and equipment consists of the following (in thousands):

 

                         
          December 31,
2012
    December 31,
2011
 
                As Restated  

Laboratory, machinery and equipment

    3-5 years     $ 28,308     $ 24,927  

Computer equipment

    3 years       4,350       3,031  

Furniture and fixtures

    5 years       899       0  

Building

    40 years       18,748       7,298  

Leasehold improvements

    Over term of lease       4,529       506  

Construction in progress

            6,412       4,106  
           

 

 

   

 

 

 

Property and equipment, gross

            63,246       39,868  

Less: Accumulated depreciation and amortization

            (26,448     (24,257
           

 

 

   

 

 

 

Property and equipment, net

          $ 36,798     $ 15,611  
           

 

 

   

 

 

 

Construction in progress assets related primarily to equipment associated with the build out of the Company’s pilot bioprocess development plant and automation laboratory which the Company placed in service during the first quarter of 2013. The pilot bioprocess development plant is expected to have a useful life of 10 years. Depreciation expense related to the Company’s new building commenced in June 2012, on the commencement date of the lease.

 

Accrued expenses

Accrued expenses consists of the following (in thousands):

 

                 
    December 31,
2012
    December 31,
2011
 
          As Restated  

Employee compensation

  $ 3,129     $ 3,138  

Professional and outside services costs

    841       1,060  

Accrued interest on debt

    262       479  

Royalties

    980       1,202  

Accrued restructuring

    61       396  

Accrued taxes

    265       36  

Other

    155       316  
   

 

 

   

 

 

 
    $ 5,693     $ 6,627